Aerovate Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Aerovate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aerovate Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aerovate Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $43k | 16k | 2.65 |
| 2024-09-30 | $488k | 233k | 2.09 |
| 2024-06-30 | $5.9k | 3.5k | 1.66 |
| 2024-03-31 | $75k | 2.5k | 29.57 |
| 2023-12-31 | $47k | 2.1k | 22.63 |
| 2023-09-30 | $2.9k | 213 | 13.57 |
| 2023-03-31 | $4.6k | 229 | 20.18 |
| 2022-12-31 | $10k | 349 | 29.30 |
| 2022-09-30 | $8.0k | 508 | 15.75 |
| 2021-12-31 | $41k | 3.5k | 11.82 |